KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tapestry (TPR) Change in Accured Expenses (2016 - 2025)

Tapestry (TPR) has disclosed Change in Accured Expenses for 17 consecutive years, with $57.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 231.12% to $57.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $131.2 million through Dec 2025, up 19.6% year-over-year, with the annual reading at $56.0 million for FY2025, 38.86% down from the prior year.
  • Change in Accured Expenses hit $57.3 million in Q4 2025 for Tapestry, up from $6.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $150.5 million in Q3 2021 to a low of -$140.3 million in Q4 2021.
  • Historically, Change in Accured Expenses has averaged $11.3 million across 5 years, with a median of -$5.4 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 7694.44% in 2021 and later skyrocketed 4903.85% in 2025.
  • Year by year, Change in Accured Expenses stood at -$140.3 million in 2021, then soared by 64.01% to -$50.5 million in 2022, then surged by 57.23% to -$21.6 million in 2023, then plummeted by 102.31% to -$43.7 million in 2024, then surged by 231.12% to $57.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for TPR at $57.3 million in Q4 2025, $6.2 million in Q3 2025, and $124.9 million in Q2 2025.